List of Tables
Table 1. Paediatric Vaccine Market Trends
Table 2. Paediatric Vaccine Market Drivers & Opportunity
Table 3. Paediatric Vaccine Market Challenges
Table 4. Paediatric Vaccine Market Restraints
Table 5. Global Paediatric Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Paediatric Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Paediatric Vaccine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Paediatric Vaccine Product Type
Table 9. Key Companies Time to Begin Mass Production of Paediatric Vaccine
Table 10. Global Paediatric Vaccine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paediatric Vaccine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Paediatric Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Paediatric Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Paediatric Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Paediatric Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Paediatric Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Paediatric Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Paediatric Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Paediatric Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Paediatric Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Paediatric Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Paediatric Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Paediatric Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Paediatric Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Paediatric Vaccine Sales Value by Region (2019-2024) & (%)
Table 27. Global Paediatric Vaccine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Paediatric Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Paediatric Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Paediatric Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 31. GlaxoSmithCline Basic Information List
Table 32. GlaxoSmithCline Description and Business Overview
Table 33. GlaxoSmithCline Paediatric Vaccine Products, Services and Solutions
Table 34. Revenue (US$ Million) in Paediatric Vaccine Business of GlaxoSmithCline (2019-2024)
Table 35. GlaxoSmithCline Recent Developments
Table 36. Merck Basic Information List
Table 37. Merck Description and Business Overview
Table 38. Merck Paediatric Vaccine Products, Services and Solutions
Table 39. Revenue (US$ Million) in Paediatric Vaccine Business of Merck (2019-2024)
Table 40. Merck Recent Developments
Table 41. Sanofi Basic Information List
Table 42. Sanofi Description and Business Overview
Table 43. Sanofi Paediatric Vaccine Products, Services and Solutions
Table 44. Revenue (US$ Million) in Paediatric Vaccine Business of Sanofi (2019-2024)
Table 45. Sanofi Recent Developments
Table 46. Bristol-Myers Squibb Basic Information List
Table 47. Bristol-Myers Squibb Description and Business Overview
Table 48. Bristol-Myers Squibb Paediatric Vaccine Products, Services and Solutions
Table 49. Revenue (US$ Million) in Paediatric Vaccine Business of Bristol-Myers Squibb (2019-2024)
Table 50. Bristol-Myers Squibb Recent Developments
Table 51. Abbott Laboratories Basic Information List
Table 52. Abbott Laboratories Description and Business Overview
Table 53. Abbott Laboratories Paediatric Vaccine Products, Services and Solutions
Table 54. Revenue (US$ Million) in Paediatric Vaccine Business of Abbott Laboratories (2019-2024)
Table 55. Abbott Laboratories Recent Developments
Table 56. Eli Lilly Basic Information List
Table 57. Eli Lilly Description and Business Overview
Table 58. Eli Lilly Paediatric Vaccine Products, Services and Solutions
Table 59. Revenue (US$ Million) in Paediatric Vaccine Business of Eli Lilly (2019-2024)
Table 60. Eli Lilly Recent Developments
Table 61. Pfizer Basic Information List
Table 62. Pfizer Description and Business Overview
Table 63. Pfizer Paediatric Vaccine Products, Services and Solutions
Table 64. Revenue (US$ Million) in Paediatric Vaccine Business of Pfizer (2019-2024)
Table 65. Pfizer Recent Developments
Table 66. F. Hoffmann-La Roche Basic Information List
Table 67. F. Hoffmann-La Roche Description and Business Overview
Table 68. F. Hoffmann-La Roche Paediatric Vaccine Products, Services and Solutions
Table 69. Revenue (US$ Million) in Paediatric Vaccine Business of F. Hoffmann-La Roche (2019-2024)
Table 70. F. Hoffmann-La Roche Recent Developments
Table 71. Novo Nordisk Basic Information List
Table 72. Novo Nordisk Description and Business Overview
Table 73. Novo Nordisk Paediatric Vaccine Products, Services and Solutions
Table 74. Revenue (US$ Million) in Paediatric Vaccine Business of Novo Nordisk (2019-2024)
Table 75. Novo Nordisk Recent Developments
Table 76. Key Raw Materials Lists
Table 77. Raw Materials Key Suppliers Lists
Table 78. Paediatric Vaccine Downstream Customers
Table 79. Paediatric Vaccine Distributors List
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Paediatric Vaccine Product Picture
Figure 2. Global Paediatric Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Paediatric Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Paediatric Vaccine Report Years Considered
Figure 5. Global Paediatric Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Paediatric Vaccine Revenue in 2023
Figure 7. Paediatric Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Pneumococcal Picture
Figure 9. Varicella Picture
Figure 10. Combinations Picture
Figure 11. Poliovirus Picture
Figure 12. Hepatitis Picture
Figure 13. MMR Picture
Figure 14. Pediatric Hormones Picture
Figure 15. HIB Picture
Figure 16. Allergy and Respiratory vaccines Picture
Figure 17. Other Pediatric vaccines Picture
Figure 18. Global Paediatric Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Paediatric Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 20. Product Picture of Age (0-3)
Figure 21. Product Picture of Age (3-12)
Figure 22. Product Picture of Age Above 12
Figure 23. Global Paediatric Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Paediatric Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 25. North America Paediatric Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Paediatric Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Paediatric Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Paediatric Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Paediatric Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Paediatric Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Paediatric Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Paediatric Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Paediatric Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Paediatric Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Paediatric Vaccine Sales Value (%), (2019-2030)
Figure 36. United States Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 37. United States Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 38. United States Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 39. Europe Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 40. Europe Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 41. Europe Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 42. China Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 43. China Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 44. China Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 45. Japan Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 46. Japan Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 47. Japan Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 48. South Korea Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 49. South Korea Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 50. South Korea Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 51. Southeast Asia Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 52. Southeast Asia Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 53. Southeast Asia Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 54. India Paediatric Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 55. India Paediatric Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 56. India Paediatric Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 57. Paediatric Vaccine Industrial Chain
Figure 58. Paediatric Vaccine Manufacturing Cost Structure
Figure 59. Channels of Distribution (Direct Sales, and Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
